Blood Vessels and Perivascular Phagocytes of Prefrontal White and Gray Matter in Suicide.


Journal

Journal of neuropathology and experimental neurology
ISSN: 1554-6578
Titre abrégé: J Neuropathol Exp Neurol
Pays: England
ID NLM: 2985192R

Informations de publication

Date de publication:
01 01 2019
Historique:
pubmed: 30 11 2018
medline: 30 11 2019
entrez: 30 11 2018
Statut: ppublish

Résumé

Inflammatory processes may contribute to psychiatric disorders and suicide. Earlier, we reported greater densities of perivascular phagocytes in dorsal prefrontal white matter (DPFWM) in suicide than in non-suicide deaths. To distinguish between greater vascularity and greater coverage of vessels by perivascular phagocytes, and to determine whether the excess of perivascular phagocytes is derived from microglia or from non-parenchymal immune cells, we made stereological estimates of vascular surface area density (AVTOTAL) by staining for glucose transporter Glut-1, and the fraction of vascular surface area (AF) immunoreactive (IR) for CD163 (CD163 AF) in dorsal and ventral prefrontal white and gray matter. Manner of death or psychiatric diagnosis showed no association with CD163 AF in any region. Suicide was associated with a lower AVTOTAL compared with non-suicides in DPFWM (p = 0.018) but not with AVTOTAL in the 3 other regions of interest. Thus, the earlier observation of increased density of perivascular phagocytes in DPFWM after suicide cannot be attributed to infiltration by peripheral monocytes or to increased vascularity. Greater AVTOTAL ventrally than dorsally (p = 0.002) was unique to suicide and white matter.

Identifiants

pubmed: 30496451
pii: 5212821
doi: 10.1093/jnen/nly103
pmc: PMC6289219
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-30

Références

Brain Behav Immun. 2014 Nov;42:50-9
pubmed: 24858659
Biol Psychiatry. 2009 Aug 1;66(3):287-92
pubmed: 19268915
Nat Immunol. 2017 Mar 22;18(4):385-392
pubmed: 28323268
Nat Neurosci. 2015 Oct;18(10):1386-93
pubmed: 26404713
Clin Neuropathol. 1999 Nov-Dec;18(6):313-7
pubmed: 10580558
Am J Pathol. 2003 Jun;162(6):2041-57
pubmed: 12759259
J Psychiatr Res. 2012 Jan;46(1):57-63
pubmed: 21906753
J Neurosci. 2014 Feb 12;34(7):2583-91
pubmed: 24523548
Brain Behav Immun. 2012 Nov;26(8):1273-9
pubmed: 22917959
Biol Psychiatry. 2008 Apr 15;63(8):801-8
pubmed: 18005941
Lancet Psychiatry. 2018 Apr;5(4):292-294
pubmed: 29496586
Schizophr Res. 2008 Jul;102(1-3):352-5
pubmed: 18486454
Eur J Neurosci. 2001 Nov;14(10):1651-8
pubmed: 11860459
Neuron. 2008 Jan 24;57(2):178-201
pubmed: 18215617
Nat Rev Neurosci. 2014 May;15(5):300-12
pubmed: 24713688
Brain Behav Immun. 2009 Oct;23(7):887-97
pubmed: 19389469
Mol Psychiatry. 2013 Feb;18(2):206-14
pubmed: 22869038
J Psychiatr Res. 2008 Jan;42(2):151-7
pubmed: 17174336
Schizophr Res. 1995 Feb;14(3):215-21
pubmed: 7766532
Am J Pathol. 2008 Mar;172(3):725-37
pubmed: 18276779
J Cell Biol. 1966 Jul;30(1):23-38
pubmed: 5338131
J Leukoc Biol. 1999 Nov;66(5):858-66
pubmed: 10577520
Neurosci Lett. 1999 Aug 20;271(2):126-8
pubmed: 10477118
Pharmacol Rev. 1997 Jun;49(2):143-55
pubmed: 9228664
Acta Neuropathol. 2006 Sep;112(3):305-16
pubmed: 16783554
J Psychiatr Res. 1992 Apr;26(2):125-34
pubmed: 1613679
Acta Neurol Scand Suppl. 1965;14:15-9
pubmed: 5214090
CNS Neurol Disord Drug Targets. 2013 Nov;12(7):971-9
pubmed: 24040799
Acta Psychiatr Scand. 2008 Mar;117(3):198-206
pubmed: 18081924
Am J Pathol. 2006 Mar;168(3):822-34
pubmed: 16507898
Mol Psychiatry. 2018 Sep 13;:null
pubmed: 30214039
Glia. 2005 Sep;51(4):297-305
pubmed: 15846794
J Am Heart Assoc. 2017 Sep 28;6(10):null
pubmed: 28963101
Neuroscience. 2015 Mar 19;289:429-42
pubmed: 25596319
Transl Psychiatry. 2012 Nov 20;2:e196
pubmed: 23168996
Front Neurosci. 2015 Jan 21;8:447
pubmed: 25653581
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
J Leukoc Biol. 2012 Nov;92(5):959-75
pubmed: 22875882
Am J Psychiatry. 1999 Nov;156(11):1725-9
pubmed: 10553735
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):796-808
pubmed: 21216267
Expert Rev Neurother. 2010 Jan;10(1):59-76
pubmed: 20021321
J Neuropathol Exp Neurol. 2014 Sep;73(9):880-90
pubmed: 25101704
Brain Behav Immun. 2011 Feb;25(2):335-9
pubmed: 20951793
Pharmaceuticals (Basel). 2010 Jan 06;3(1):19-41
pubmed: 27713241
Acta Psychiatr Scand. 1993 Jul;88(1):48-52
pubmed: 8372695
Biol Psychiatry. 2010 Mar 1;67(5):446-57
pubmed: 20015486
Brain Res Bull. 1981 Nov;7(5):519-79
pubmed: 7317796
Bipolar Disord. 2013 Aug;15(5):524-41
pubmed: 23773657
Schizophr Res. 2001 Jan 15;47(1):13-25
pubmed: 11163541
Nat Immunol. 2016 Jul;17(7):797-805
pubmed: 27135602
Magn Reson Med. 2006 Nov;56(5):1145-50
pubmed: 17029231
J Chem Neuroanat. 2017 Mar;80:A1-A8
pubmed: 27988177
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16136-41
pubmed: 25331895
J Exp Med. 2014 Jul 28;211(8):1533-49
pubmed: 25002752
Front Neurosci. 2014 Aug 08;8:239
pubmed: 25152709
Brain Behav Immun. 2005 Nov;19(6):555-63
pubmed: 16214026
Biol Psychiatry. 2011 Jan 15;69(2):134-9
pubmed: 21035789
J Neurosci Res. 1989 Jan;22(1):103-6
pubmed: 2926837
Brain Behav Immun. 2016 May;54:260-277
pubmed: 26851553
World Psychiatry. 2002 Oct;1(3):181-5
pubmed: 16946849
Biol Psychiatry. 2011 Oct 1;70(7):663-71
pubmed: 21641581
J Immunol Res. 2016;2016:1475435
pubmed: 27478854
J Theor Biol. 2011 Oct 7;286(1):67-78
pubmed: 21782831
Neuroscience. 2013 Aug 29;246:199-229
pubmed: 23644052
Transl Psychiatry. 2011 Aug 09;1:e28
pubmed: 22832602
Clin Immunol Immunopathol. 1996 Jan;78(1):83-5
pubmed: 8599889
Glia. 2002 Mar 1;37(3):229-40
pubmed: 11857681
World J Biol Psychiatry. 2012 Sep;13(6):468-73
pubmed: 22098148
Brain Pathol. 2002 Oct;12(4):442-55
pubmed: 12408230
Neuropsychopharmacology. 2003 Aug;28(8):1515-20
pubmed: 12799618
Clin Dev Immunol. 2013;2013:608654
pubmed: 23690824
Neuropathol Appl Neurobiol. 2009 Jun;35(3):306-28
pubmed: 19077109
Trends Neurosci. 2016 Jun;39(6):353-355
pubmed: 27130658
Psychoneuroendocrinology. 2016 Jan;63:296-310
pubmed: 26546783
J Biol Chem. 1987 Apr 25;262(12):5576-80
pubmed: 3553180

Auteurs

Tatiana P Schnieder (TP)

Division of Molecular Imaging and Neuropathology, Department of Psychiatry, Columbia University, New York, New York.
New York State Psychiatric Institute, New York, New York.

Isaiah D Zhou Qin (ID)

Columbia University School of Professional Studies, Columbia University, New York, New York.

Iskra Trencevska-Ivanovska (I)

Psychiatric Hospital, Skopje, R. Macedonia.

Gorazd Rosoklija (G)

Division of Molecular Imaging and Neuropathology, Department of Psychiatry, Columbia University, New York, New York.
New York State Psychiatric Institute, New York, New York.
Macedonian Academy of Sciences and Arts, Skopje, R. Macedonia.

Aleksandar Stankov (A)

School of Medicine, University "Ss.Cyril and Methodius", Skopje, R. Macedonia.

Goran Pavlovski (G)

School of Medicine, University "Ss.Cyril and Methodius", Skopje, R. Macedonia.

J John Mann (JJ)

Division of Molecular Imaging and Neuropathology, Department of Psychiatry, Columbia University, New York, New York.
New York State Psychiatric Institute, New York, New York.

Andrew J Dwork (AJ)

Division of Molecular Imaging and Neuropathology, Department of Psychiatry, Columbia University, New York, New York.
New York State Psychiatric Institute, New York, New York.
Macedonian Academy of Sciences and Arts, Skopje, R. Macedonia.
Department of Pathology and Cell Biology, Columbia University, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH